发明名称 Direct Lipid to Membrane Drug Delivery
摘要 Described herein is a method of delivering hydrophilic drugs directly from a hydrophobic carrier and/or excipient to absorbing cell membranes. More specifically, CaNa2 EDTA is delivered rectally from a suppository containing methylbutylketone in a carrier as an excipient.
申请公布号 US2014275259(A1) 申请公布日期 2014.09.18
申请号 US201414207424 申请日期 2014.03.12
申请人 APPLIED BIORESEARCH, INC. 发明人 Palmer James F.;Settineri Robert A.
分类号 A61K31/198 主分类号 A61K31/198
代理机构 代理人
主权项 1. A suppository for use in chelating heavy metals in a living being comprising: i. calcium disodium ethylenediaminetetraacetate (CaNa2 EDTA), ii. a hydrophobic excipient, and iii. a carrier comprising one or more of glycerin, glyceryl monopalmitate, glyceryl monostearate, hydrogenated coconut oil fatty acids, cocoa butter, and fatty acids.
地址 Draper UT US